BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.
Company profile
Website
CEO
Joseph Capper
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BioTelemetry, Inc.
SEC CIK
Corporate docs
Subsidiaries
BioTel Research, LLC • BioTelemetry Care Management, LLC • Braemar Manufacturing, LLC • Card Guard Europe BV • Cardiac Monitoring Holding Company, LLC • CardioNet, LLC • Geneva Healthcare, LLC • LifeWatch Corp. • LifeWatch GmbH • LifeWatch Services Inc. ...
IRS number
462568498
Latest filings (excl ownership)
15-12G
Securities registration termination
19 Feb 21
POSASR
Automatic shelf registration (post-effective amendment)
9 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 21
8-K
Termination of a Material Definitive Agreement
9 Feb 21
25-NSE
Exchange delisting
9 Feb 21
SC 14D9/A
Tender offer solicitation (amended)
9 Feb 21
Transcripts
Earnings call transcript
2020 Q3
29 Oct 20
Earnings call transcript
2020 Q2
30 Jul 20
Earnings call transcript
2020 Q1
6 May 20
Earnings call transcript
2019 Q4
26 Feb 20
Earnings call transcript
2019 Q3
5 Nov 19
Earnings call transcript
2019 Q2
30 Jul 19
Earnings call transcript
2019 Q1
26 Apr 19
Earnings call transcript
2018 Q4
22 Feb 19
Earnings call transcript
2018 Q3
30 Oct 18
Earnings call transcript
2018 Q2
25 Jul 18
Latest ownership filings
SC 13G/A
ArrowMark Colorado Holdings LLC
10 Mar 21
SC 13G/A
ArrowMark Colorado Holdings LLC
16 Feb 21
4
Heather C Getz
11 Feb 21
4
Andrei G Stoica
11 Feb 21
4
Fred Broadway
11 Feb 21
4
Joseph A. Frick
11 Feb 21
4
ROBERT J. RUBIN
11 Feb 21
4
Colin Hill
11 Feb 21
4
Manish Wadhwa
11 Feb 21
4
Joseph H Capper
11 Feb 21
Financial summary
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|